{
  "main_header": {
    "sid": 930938,
    "name": "Gennex Lab.",
    "stock_name": "Gennex Lab.",
    "full_name": "Gennex Laboratories Ltd",
    "name_url": "stocks-analysis/gennex-lab",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "9.41",
    "chg": 0.86,
    "chgp": "10.06%",
    "dir": 1,
    "prev_price": "8.55",
    "mcapval": "214.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 531739,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE509C01026",
    "curr_date": "Apr 02",
    "curr_time": "",
    "bse_nse_vol": "11.16 lacs",
    "exc_status": "Active",
    "traded_date": "Apr 02, 2026",
    "traded_date_str": "2026 04 02",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://uat-researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/gennex-lab-930938-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [],
    "total": 131,
    "sid": "930938",
    "stock_news_url": "https://uat-researchintel.adityabirlamoney.com/news/gennex-laboratories-930938"
  },
  "announcements": [
    {
      "caption": "Closure of Trading Window",
      "datetime": "25-Mar-2026",
      "details": "Notice is hereby given that in pursuance of SEBI (PIT) Regulations 2015 and Companys Code of Conduct for Regulating Monitoring and Reporting of Trading by Insiders the Trading Window for dealing in the Securities of the Company shall remain closed from April 01 2026 till 48 hours after the public announcement through Board of Directors in their meeting held for announcing the audited Financial Results for the Quarter and year ended on March 31 2026 along with other matters for which Trading window is required to be closed. The Board Meeting Date to approve the audited financial results of the Company for the Quarter and year ended on March 31 2026 will be informed in due course. All Promoters/designated/connected persons are advised not to trade in the securities of the Company directly or indirectly during the aforesaid period of Closure of Trading Window. We request you to take the above information on record and acknowledge receipt of the same.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "17-Feb-2026",
      "details": "Pursuant to Regulation 47 of SEBI (LODR) Regulations 2015 please find enclosed herewith Newspaper Publication on Unaudited (Standalone & Consolidated) Financial Results for the Quarter and Nine months ended December 31 2025 announced by the Board of Directors in its meeting held on Saturday February 14 2026. Financial Results had been published in both Business Standard (English) and Saksham ( Telugu-Local) on Monday February 16 2026. We request you to take the above information on record and acknowledge receipt of the same.",
      "source": "BSE"
    },
    {
      "caption": "Quarter And Nine Months Ended December 31 2025",
      "datetime": "14-Feb-2026",
      "details": "Unaudited (Standalone and Consolidated) Financial Results for 31.12.2025 along with Limited Review Report thereon.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Gennex Laboratories Ltd has announced <strong>1:10</strong> stock split, ex-date: 14 Dec 09",
          "dt": "2009-12-14",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Gennex Laboratories Ltd has announced <strong>1:2</strong> rights issue, ex-date: 21 Jul 22",
          "dt": "2022-07-21",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

No Recent News for the Company

View All News